Altus Pharmaceuticals Inc.
Records under this name other than patents Altus Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Altus Pharmaceuticals Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,155,785 | Crystallized oxalate decarboxylase and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,821,041 | Crystallized oxalate decarboxylase and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,369,203 | Crystallized oxalate decarboxylase and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,142,775 | Crystallized oxalate decarboxylase and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,741,284 | Crystallized oxalate decarboxylase and methods of use Formerly held Lapsed on the fee record Ended Jun 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2026 | From the USPTO record |
| US 11,135,212 | Method for treating osteoporosis, osteopenia or low bone mineral density Lapsed on the fee record Ended Oct 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2025 | From the USPTO record |
| US 9,725,471 | Method to prevent cancer metastasis to bone Lapsed on the fee record Ended Aug 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 8, 2025 | From the USPTO record |
| US 10,933,021 | Compositions of gallium (III) complexes for oral administration Lapsed on the fee record Ended Mar 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 2, 2025 | From the USPTO record |
| US 9,376,479 | Human growth hormone crystals and methods for preparing them Formerly held Term ended Term ended Oct 14, 2024 · From the USPTO record | Term ended | Term ended Oct 14, 2024 | From the USPTO record |
| US 10,548,849 | Compositions of gallium (III) complexes for oral administration Lapsed on the fee record Ended Feb 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2024 | From the USPTO record |